Betahistine Hydrochloride
Who holds supplier records for Betahistine Hydrochloride? 9 organisations hold a current record for Betahistine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), Italy (1), Germany (1) and Spain (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Betahistine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/betahistine-hydrochloride
Reading the evidence
- 9 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
5 of the 8 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (9)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Betahistine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Maithri Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 41583 · latest filing Mar 2025
- OLON SPAItalyCEP Company GMP cert on recordActive DMF 19495 · latest filing Jun 2006
- HENAN PURUI PHARMACEUTICAL CO LTDActive DMF 36103 · latest filing Jul 2021
- IndiaCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- GermanyCEP
- IndiaCEP
- Laboratorios Espinos Y Bofill S.A.SpainCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (8)
Certificates of Suitability on the EDQM register for Betahistine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam Village | IN | CEP 2025-260 - Rev 00 Betahistine dihydrochloride | Sept 2026 | — |
| Grunenthal GmbH Aachen | DE | CEP 2009-001 - Rev 03 Betahistine dihydrochloride | Oct 2025 | Inspected Nov 2024 Germany |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District | IN | CEP 2022-505 - Rev 02 Betahistine dihydrochloride | Sept 2025 | — |
| Laboratorios Espinos Y Bofill S.A. Cornella de Llobregat | ES | CEP 2009-177 - Rev 03 Betahistine dihydrochloride | Dec 2024 | Inspected Apr 2023 Spain, outside 3-year window |
| AMI LIFESCIENCES PRIVATE LIMITED Karakhadi | IN | CEP 2011-101 - Rev 04 Betahistine dihydrochloride | Jul 2024 | Inspected Oct 2025 Slovakia |
| COHANCE LIFESCIENCES LIMITED Mumbai | IN | CEP 2013-240 - Rev 02 Betahistine dihydrochloride | Jul 2024 | — |
| OLON S.P.A. Rodano | IT | CEP 2006-316 - Rev 05 Betahistine dihydrochloride | Jul 2024 | Inspected Mar 2025 Italy |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2012-058 - Rev 01 Betahistine dihydrochloride | Nov 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Betahistine Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1446813).
Chemical identity
- IUPAC name
- N-methyl-2-pyridin-2-ylethanamine;dihydrochloride
- Canonical SMILES
- CNCCC1=CC=CC=N1.Cl.Cl
- InChIKey
- XVDFMHARQUBJRE-UHFFFAOYSA-N
- Synonyms
- Betahistine dihydrochloride, Betahistine hcl, Betahistine hydrochloride, NSC-757397, PT-9, Serc-16, Serc-8, Serc, Betaserc, RefChem:567992, Betahistine 2HCl, Microser
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Betahistine Hydrochloride?
9 organisations hold an active US FDA Type II Drug Master File or a CEP for Betahistine Hydrochloride: Maithri Laboratories Private Limited (India), OLON SPA (Italy), HENAN PURUI PHARMACEUTICAL CO LTD, AMI LIFESCIENCES PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India), COHANCE LIFESCIENCES LTD (India), Grünenthal GmbH (Germany) and MATRIX PHARMACORP PRIVATE LTD (India), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Betahistine Hydrochloride Drug Master Files are active?
Maithri Laboratories Private Limited (DMF 41583), OLON SPA (DMF 19495) and HENAN PURUI PHARMACEUTICAL CO LTD (DMF 36103). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Betahistine Hydrochloride have a European Certificate of Suitability?
Yes. 8 organisations hold a valid CEP for Betahistine Hydrochloride on the EDQM register, including MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam Village (IN), Grunenthal GmbH Aachen (DE), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), Laboratorios Espinos Y Bofill S.A. Cornella de Llobregat (ES), AMI LIFESCIENCES PRIVATE LIMITED Karakhadi (IN) and COHANCE LIFESCIENCES LIMITED Mumbai (IN) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Betahistine Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Betahistine Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.